BioNTech (NASDAQ:BNTX) just reported results for the first quarter of 2024.
- BioNTech reported earnings per share of -$1.42. This was below the analyst estimate for EPS of -$1.17.
- The company reported revenue of $203.74 million.
- This was 55.76% worse than the analyst estimate for revenue of $460.50 million.